IAMGOLD reports record 2025 results as revenue hits $2.85B
IAMGOLD (NYSE:IAG) reported record-breaking financial and operating results for 2025, fueled by the successful ramp-up of its flagship Côté Gold mine and a historic rally in gold prices.
Every story in this section, newest first — page 285 of 373.
IAMGOLD (NYSE:IAG) reported record-breaking financial and operating results for 2025, fueled by the successful ramp-up of its flagship Côté Gold mine and a historic rally in gold prices.
Fiverr International (NYSE:FVRR) posted full-year 2025 revenue of $430.9 million, an increase of 10.1% from the prior year, driven primarily by strong performance in its higher-margin services business.
ICL Group (NYSE:ICL), a leading global specialty minerals company, delivered higher fourth-quarter sales and adjusted profitability for 2025, driven by resilient demand in its core specialty crop nutrition and food solutions businesses.
Outlook Therapeutics (NASDAQ:OTLK) posted a net loss attributable to common stockholders of $23.1 million, or $0.38 per basic and diluted share, for the fiscal first quarter ended December 31, 2025.
Builders FirstSource (NYSE:BLDR) reported a significant decline in fourth-quarter profitability, as the nation's largest supplier of structural building products grappled with a "below-normal" environment for new residential housing starts and persistent commodity deflation.
Teva Pharmaceutical Industries (NYSE:TEVA) and Sanofi (NASDAQ:SNY) announced a major clinical victory on Tuesday, revealing that their investigational antibody, duvakitug (formerly TEV-574), successfully maintained disease control in patients with inflammatory bowel disease (IBD) for nearly a full year.
Datavault AI (NASDAQ:DVLT) surged in early trading Tuesday after the data-monetization specialist sharply raised its fiscal 2025 revenue outlook, citing an "exceptional" acceleration in enterprise AI adoption and licensing fees.
Daily Journal (NASDAQ:DJCO) posted first-quarter fiscal 2026 revenue of $19.5 million, up 10% from $17.7 million in the year-ago period.
Enlight Renewable Energy (NASDAQ:ENLT) delivered a record-shattering fourth-quarter performance on Tuesday, as the global energy developer capitalized on a surge in U.S. solar and storage demand to handily exceed its full-year guidance.
National Energy Services Reunited (NASDAQ:NESR) delivered a powerhouse performance for the fourth quarter on Tuesday, as a sharp acceleration in Middle Eastern field activity propelled the company toward a record-breaking 2026.
Medtronic (NYSE:MDT) reported third-quarter fiscal 2026 revenue of $9.017 billion, an increase of 8.7% as reported and 6.0% on an organic basis, surpassing the midpoint of its guidance by 50 basis points and marking the highest enterprise revenue growth in the past 10 quarters.
Fluor (NYSE:FLR) reported a volatile set of full-year 2025 results on Tuesday, as the engineering and construction giant navigated a major legal setback and a dramatic restructuring of its balance sheet.
Valmont Industries (NYSE:VMI) reported fourth-quarter fiscal 2025 net sales of $1.04 billion, essentially flat year over year with a 0.1% increase, as growth in key infrastructure segments was offset by softer demand in certain agricultural markets.
Vulcan Materials Company (NYSE: VMC) reported full-year 2025 adjusted EBITDA of $2.324 billion, an increase of 13% from the prior year, marking a record high for the company.
Danaher (NYSE:DHR) announced it has signed a definitive agreement to acquire all outstanding shares of Masimo Corporation for $180 per share in cash, valuing the deal at approximately $9.9 billion on an enterprise basis.
Harmony Biosciences Holdings (NASDAQ:HRMY) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for WAKIX® (pitolisant) to treat cataplexy in pediatric patients aged six years and older.
Pfizer (NYSE:PFE) today reported positive topline results from Cohort 3 of its pivotal Phase 3 BREAKWATER trial, marking a significant milestone in the treatment of one of the most aggressive forms of colorectal cancer.
SunCoke Energy (NYSE:SXC) reported a full-year 2025 net loss attributable to SXC of $44.2 million, or $0.52 per diluted share, compared with prior-year performance, primarily due to unfavorable one-time items totaling $109.3 million pre-tax ($83.1 million net of tax).
eToro Group (NASDAQ:ETOR) posted full-year 2025 net contribution of $868 million, an increase of 10% from $788 million in 2024, reflecting resilient user engagement and monetization across trading, investing, and crypto activities despite market volatility.
Ceragon Networks (NASDAQ:CRNT) reported fourth-quarter and full-year 2025 results on Tuesday that aligned with its January preliminary update, signaling a year of operational stabilization and a clearing path for double-digit growth in 2026.
Waystar Holding (NASDAQ:WAY) reported fourth-quarter 2025 revenue of $303.5 million, an increase of 24% year over year, contributing to full-year revenue of $1,099.3 million, up 17% from 2024.
Donnelley Financial Solutions (NYSE:DFIN) delivered a decisive fourth-quarter performance on Tuesday, showcasing the financial muscle of its multi-year transition from a legacy commercial print business into a high-margin regulatory software provider.
Watsco (NYSE:WSO) posted full-year 2025 revenues of $7.24 billion, down 5% from the prior year, reflecting headwinds in equipment volumes offset partially by an 11% increase in average domestic selling prices and contributions from parts and supplies.
Hillman Solutions (NASDAQ:HLMN) reported record full-year 2025 net sales of $1.55 billion, an increase of 5.4% from 2024, driven by strength across its fastener, keys, and protective solutions categories, as well as contributions from merchandising innovations and expanded retail partnerships.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy